The Thiamine Administration After Cardiac Surgery Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

October 3, 2022

Study Completion Date

October 3, 2022

Conditions
Lactate Blood IncreaseThiamine Deficiency
Interventions
DRUG

Thiamine 500 MG

A solution of 500 mg of Thiamine Hydrocloride in a solution of 100 ml of NaCl 0.9% will be administered post-cardiac surgery in patients with lactate levels ≥ 2 mmol / L in the first 6 hours post-ICU admission.

DRUG

Placebo

100 ml of NaCl 0.9% will be administered in the placebo group.

Trial Locations (1)

Unknown

CHU-Charleroi Hopital Civil Marie Curie, Charleroi

All Listed Sponsors
collaborator

CHU de Charleroi

OTHER

lead

Sarah Saxena

OTHER

NCT04641104 - The Thiamine Administration After Cardiac Surgery Trial | Biotech Hunter | Biotech Hunter